IESE (España)
-
Nuevas lentes para ver los mercados emergentes
Khanna, Tarun; Palepu, KrishnaArticle ART-2385StrategyCuando se habla de mercados emergentes, pensamos inmediatamente en los BRIC. Esta simplificación ha llevado a ver estas economías como un conjunto homogéneo, cuando la realidad es justamente la contraria. En lugar de apresurarse a elaborar una estrategia para Brasil, Rusia, India o China, a las empresas les convendría estudiar en qué aspectos es emergente cada país en concreto. Puede que se lleven una sorpresa. En este artículo, los autores resum...Starting at €8.20
-
New Immuno-Oncology Solutions (NIOS): Aligning Stakeholders in the Biotech Industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacCase SM-1701-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €8.20
-
New Immuno-Oncology Solutions (NIOS) - Teaching Note: Aligning stakeholders in the biotech industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacTeaching Note SMT-136-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €0.00
-
Emerging Markets: Look Before You Leap
Khanna, Tarun; Palepu, KrishnaArticle ART-2385-EStrategyThink "emerging markets," and most people think BRICs. The problem with this approach is that it is too simplistic and tends to treat emerging markets as one homogeneous whole, when the exact opposite is true. Instead of asking, "What's my emerging market strategy for Brazil, Russia, India or China?" companies should ask themselves, "In which ways is this particular market emerging?" Viewed this way, the answer may surprise them. The authors synt...Starting at €8.20